Lane, J., Weaver, J., Kostka, K., Duarte-Salles, T., Abrahão, M., Alghoul, H., Alser, O., Alshammari, T., Areia, C., Biedermann, P., Banda, J., Burn, E., Casajust, P., Fišter, K., Hardin, J., Hester, L., Hripcsak, G., Kaas-Hansen, B., Khosla, S., Kolovos, S., Lynch, K., Makadia, R., Mehta, P., Morales, D., Morgan-Stewart, H., Mosseveld, M., Newby, D., Nyberg, F., Ostropolets, A., Woong Park, R., Prats-Uribe, A., Rao, G., Reich, C., Rijnbeek, P., Sena, A., Shoaibi, A., Spotnitz, M., Vignesh, S., Suchard, M., Vizcaya, D., Wen, H., de Wilde, M., Xie, J., You, S., Zhang, L., Lovestone, S., Ryan, P. & Prieto-Alhambra, D. 2020, 'Risk of depression, suicide and psychosis with hydroxychloroquine treatment for rheumatoid arthritis: a multinational network cohort study', Rheumatology, article no: keaa771. https://doi.org/10.1093/rheumatology/keaa771